ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 85 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,392,000 | -38.7% | 920,173 | -8.3% | 0.00% | -100.0% |
| Q3 2016 | $3,905,000 | +50.9% | 1,003,787 | +4.3% | 0.00% | – |
| Q2 2016 | $2,588,000 | +51.3% | 962,026 | +73.3% | 0.00% | – |
| Q1 2016 | $1,710,000 | -20.0% | 555,052 | 0.0% | 0.00% | – |
| Q4 2015 | $2,137,000 | +60.6% | 555,052 | +27.2% | 0.00% | – |
| Q3 2015 | $1,331,000 | +73.3% | 436,382 | +141.0% | 0.00% | – |
| Q2 2015 | $768,000 | -47.1% | 181,102 | -51.8% | 0.00% | – |
| Q1 2015 | $1,451,000 | -16.7% | 375,864 | +45.2% | 0.00% | – |
| Q4 2014 | $1,742,000 | +19.3% | 258,792 | -2.7% | 0.00% | – |
| Q3 2014 | $1,460,000 | -49.7% | 265,891 | -6.2% | 0.00% | – |
| Q2 2014 | $2,905,000 | -10.8% | 283,458 | +4.5% | 0.00% | -100.0% |
| Q1 2014 | $3,258,000 | +7.8% | 271,289 | +1.5% | 0.00% | 0.0% |
| Q4 2013 | $3,023,000 | +5.6% | 267,280 | +0.7% | 0.00% | 0.0% |
| Q3 2013 | $2,862,000 | +45.4% | 265,487 | +25.0% | 0.00% | – |
| Q2 2013 | $1,968,000 | – | 212,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |